Modern views on clinical and economical effectiveness of rosuvastatin

Clinical trial and meta-analyis data demonstrate the important role of lipid-lowering therapy in reducing the risk of coronary heart disease (CHD) complications and CHD death. Practitioners need additional information to select from the already available statins the one that is not only effective an...

Full description

Saved in:
Bibliographic Details
Main Authors: S. K. Zyryanov, Yu. B. Belousov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1090
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinical trial and meta-analyis data demonstrate the important role of lipid-lowering therapy in reducing the risk of coronary heart disease (CHD) complications and CHD death. Practitioners need additional information to select from the already available statins the one that is not only effective and safe, but also the most acceptable from the pharmaco-economical point of view. The research data available support high efficacy, good safety profile, and clinic-economical effectiveness of a new synthetic statin - rosuvastatin.
ISSN:1728-8800
2619-0125